Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

15articles mentioning drugs

83drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Elafibranor ×

Elafibranor

This drug is selected. Its supporting articles are shown below.

ELAFIBRANOR15

Articles mentioning Elafibranor

15 articles · page 2 of 2

P55 Long-term elafibranor leads to biochemical and symptomatic improvements for at least 3 years in patients with primary biliary cholangitis (PBC)

gutjnl · abstract · 2026-06-23 · 1 matching annotations

94.0%

Elafibranor ELA PBC Numeric Rating Scale NCT04526665 fibrosis

…Introduction Elafibranor (ELA), a peroxisome proliferator-activated receptor (PPAR)α/PPA…

P65 Real-world experience of seladelpar among patients with primary biliary cholangitis including patients switched from obeticholic acid

gutjnl · abstract · 2026-06-23 · 1 matching annotations

91.7%

Seladelpar UDCA fenofibrate elafibranor Obeticholic acid ursodeoxycholic acid (UDCA)OCA SEL-2L OCA-switch Primary biliary cholangitis (PBC)

… was recently withdrawn from the US creating a therapeutic gap. Seladelpar (SEL), approved in 2024 in the US for patients with PBC and an …

P126 Introduction of an online hepatology prescription request form and virtual prescribing clinic leads to improvements in efficiency and patient satisfaction

gutjnl · abstract · 2025-10-06 · 1 matching annotations

94.8%

Mercaptopurine Carvedilol Mycophenolate Omeprazole Budesonide Lamivudine Bulevirtide Azathioprine Lansoprazole Tacrolimus+8 more

…Immunosuppression 100 (27%)• Azathioprine (38)• Budesonide (7)• Mercaptopurine (5)• Mycophenolate (40)• Prednisolone (4)• Tacrolimus (6) Prima…